Last year the 1/2 year was released on Thursday 14 February 2013, so we may have a few weeks to go. Cant see anything too surprising coming out in the data.
More interested in the Oncology review in the US - I believe it is this one -Jan 24 - 26
Clinical and Multidisciplinary Hematology and Oncology 2014, the 11th Annual Review. A great place to put the best sales team forward and work the participants.
Anyone going to this? Would be very interested in the chatter from the sales teams.
$17.50 - would love to see it, but if it came to pass in a hurry then what does one do? Sell out or hold on? Life can be so demanding at times.
price may be over reaction and over extended, page-25
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.78M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.3¢ | 18.0¢ | $109.7K | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11628739 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 5865798 | 21 |
View Market Depth
| Last trade - 15.10pm 17/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |